glp 1 agonist list of medications GLP-1/GIP Receptor Agonists and Diabetic Retinopathy: What ODs Should list of glp-1 agonists Practice
Description
Experts say that while the findings are promising, more research is still needed
Journal of Clinical Medicine, 12 (1), 145
Management of cardiovascular diseases in patients with obesity
Zepbound demonstrated 20.9% mean body weight reduction in SURMOUNT-1 at 15mg surpassing semaglutides 15% benchmark and establishing dual GIP/GLP-1 agonism as the dominant next-generation obesity mechanism
Beyond the monoaminergic hypothesis: neuroplasticity and epigenetic changes in a transgenic mouse model of depression
20,21 The aforementioned observations have provided the rationale for repurposing and developing GLP-1 RAs as psychiatric drugs
